Table 1

Baseline characteristics of the patients according to the seroconversion or not
Variables All patients (n = 97) Nonresponders (n = 67) Responders (n = 30) P-value
Age (years) 60.9 ± 12.6 63.1 ± 12.0 56.3 ± 12.6 0.012
Sex (Male,%) 54 (56.7) 35 (53.0) 19 (61.3) 0.445
Diabetes Mellitus (%) 62 (63.9) 44 (65.7) 18 (60.0) 0.591
Body mass index (Kg/m2) 22.7 ± 3.5 22.7 ± 3.6 22.8 ± 3.4 0.898
Duration of dialysis (mo)* 41.0 (25–41) 37.5 (22.8-66.3) 53.0 (31.0-82.0) 0.082
KT/V 1.44 ± 0.32 1.44 ± 0.33 1.41 ± 0.28 0.705
Urea reduction rate (%) 69.3 ± 7.9 70.0 ± 7.8 67.8 ± 8.2 0.193
Hepatitis B or C (%) 8 (8.2) 5 (7.5) 3 (10.0) 0.708
Medications (%)
Angiotensin converting enzyme inhibitor 18 (18.6) 11 (16.4) 7 (23.3%) 0.418
Angiotensin II receptor blocker 60 (61.9) 37 (55.2) 23 (76.7) 0.044
Calcium channel blocker 60 (61.9) 41 (61.2) 19 (63.3) 0.841
Beta blocker 49 (50.5) 30 (44.8) 19 (63.3) 0.194
Diuretics 53 (54.6) 38 (56.7) 15 (50.0) 0.539
Statins 40 (42.3) 28 (41.8) 12 (40.0) 0.868
Vitamin D analogue 5 (5.2) 4 (6.0) 1 (3.3) 0.587
White blood cell (/mm3) 6,450 ± 1,846 6,490 ± 1,977 6,368 ± 1,561 0.765
Lymphocyte count (/mm3) 1,376 ± 547 1,432 ± 568 1,225 ± 479 0.313
Hemoglobin (g/dL) 10.2 ± 1.1 10.0 ± 1.14 10.5 ± 0.85 0.032
MCV (fL) 93.7 ± 5.1 94.4 ± 5.3 91.4 ± 3.6 0.075
MCH (pg) 30.9 ± 1.7 31.1 ± 1.7 30.4 ± 1.3 0.153
MCHC (g/dL) 33.1 ± 1.1 33.0 ± 1.1 33.2 ± 1.1 0.546
Ferritin (ng/mL)* 159 (107–255) 159 (98–255) 155 (108–259) 0.367
C-reactive protein (mg/L)* 1.1 (0.5-4.7) 1.1 (0.5-4.3) 2.5 (0.45-6.1) 0.446
Glucose (mg/dL) 133 ± 48 134 ± 48 130 ± 48 0.74
Uric acid (mg/dL) 7.3 ± 1.3 7.2 ± 1.3 7.4 ± 1.4 0.241
Total Cholesterol (mg/dL) 149 ± 35 153 ± 40 149 ± 27 0.477
Albumin (g/dL) 4.0 ± 0.4 4.0 ± 0.4 4.0 ± 0.3 0.874
Alkaline phosphatase (IU/L) 91 ± 55 84 ± 50 101 ± 62 0.170
Total bilirubin (mg/dL) 0.31 ± 0.14 0.32 ± 0.15 0.29 ± 0.12 0.422
Triglyceride (mg/dL) 129 ± 94 133 ± 106 117 ± 60 0.351
HDL-cholesterol (mg/dL) 38 ± 13 37 ± 13 41 ± 14 0.332
Intact-parathyroid hormone (pg/mL) 160 ± 97 148 ± 96 188 ± 97 0.069

* was expressed by median (interquartile range).

Moon et al.

Moon et al. BMC Nephrology 2012 13:165   doi:10.1186/1471-2369-13-165

Open Data